Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.

ED is characterized by the inability to achieve or maintain an erection sufficient for sexual activity. It can be caused by various factors, including physical conditions such as cardiovascular ...

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

It’s no surprise that many people are uncomfortable talking to a doctor about erectile dysfunction. The shame and embarrassment that people with this condition often feel can affect relationships, ...

Personality traits and mental health problems are among the factors linked to erectile dysfunction (ED), a condition that affects up to 80% of men over the age of 60. But researchers often overlook ...

Shock-wave therapy looks like an effective method for treating erectile dysfunction (ED), but injections of platelet-rich plasma (PRP) proved no better than placebo, according to results from two ...

The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...